Author | Vivek Subbiah, MD | OncLive

Author | Vivek Subbiah, MD

Articles

Dr. Subbiah on the Utility of Tivozanib in RCC

May 20, 2020

Video

Vivek Subbiah, MD, discusses the utility of tivozanib in renal cell carcinoma.

Dr. Subbiah on the Importance of Tivozanib in RCC

May 20, 2020

Video

Vivek Subbiah, MD, discusses the utility of tivozanib in renal cell carcinoma.

Dr. Subbiah on Safety and Efficacy of BLU-667 in RET-Altered Solid Tumors

April 16, 2018

Video

Vivek Subbiah, MD, associate medical director, Clinical Center for Targeted Therapy, assistant professor, Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses the safety and efficacy findings of BLU-667 in RET-altered solid tumors in an interview during the 2018 AACR Annual Meeting.

x